These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3567519)

  • 21. Estradiol and progesterone receptors in breast cancer: prognostic value after relapse.
    Bonneterre J; Horner D; Peyrat JP; Vandewalle B; Cambier L; Demaille A
    Breast Cancer Res Treat; 1985; 5(2):149-54. PubMed ID: 4016280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
    Howat JM; Harris M; Swindell R; Barnes DM
    Br J Cancer; 1985 Feb; 51(2):263-70. PubMed ID: 3966982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
    Thorpe SM; Rose C
    Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone receptors (ER, PgR) as a prognostic factor in breast cancer].
    Kimura M; Koida T; Shimizu Y; Fukuda T; Sakaue S; Nakamura S
    Gan No Rinsho; 1988 Aug; 34(9):1083-8. PubMed ID: 3172513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen and progesterone receptor distribution in the cancerous breast.
    Panahy C; Puddefoot JR; Anderson E; Vinson GP; Berry CL; Turner MJ; Brown CL; Goode AW
    Br J Cancer; 1987 Apr; 55(4):459-62. PubMed ID: 3580270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of steroid hormone receptor analysis in predicting time to treatment failure in operable breast cancer.
    Klein B; Falkson G; Terblanche AP; Klein T; Potgieter HC; Smit CF
    S Afr Med J; 1986 Mar; 69(5):283-6. PubMed ID: 3961607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
    Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progesterone receptor assays on breast carcinoma from mastectomy specimens.
    Meyer JS; Schechtman K; Valdes R
    Cancer; 1983 Dec; 52(11):2139-43. PubMed ID: 6627219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA; Davidson AL; Kopel S; Schreibman B; Gelbfish JS; Degenshein GA; Herz BL; Cunningham JN
    Ann Surg; 1988 Jan; 207(1):75-9. PubMed ID: 3337566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and progesterone receptor content of primary and secondary breast carcinoma: influence of time and treatment.
    Mobbs BG; Fish EB; Pritchard KI; Oldfield G; Hanna WH
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):819-26. PubMed ID: 3653198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone receptors in breast cancer: a conservative determination of receptors' presence in tumor tissue and ipsilateral normal mammary gland.
    Badellino F; Canavese G; Catturich A; Battistini G; Amoretti G; Bertoglio S; Boccardo F; Paganuzzi M; Tanara G
    J Surg Oncol; 1988 Feb; 37(2):89-93. PubMed ID: 3343845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer.
    Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P
    Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of progesterone receptor status and age in relation to axillary node status in breast cancer patients.
    Collett K; Skjaerven R; Thorsen T; Hartveit F; Maehle BO
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):959-64. PubMed ID: 2753058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.